Dose escalation and pharmacodynamic study of intravenous adminstration of Reolysin, a live replication competent RNA virus in patients with advanced solid tumors

被引：0
|
作者：
Ghalib, M. H.
Desai, K. K.
Gollamudi, R.
Chaudhary, I.
Einstein, M.
Coffey, M.
Mettinger, K.
Mani, S.
Goel, S.
机构：
[1] Montefiore Med Ctr, Bronx, NY 10467 USA
[2] Oncolytics Biotech Inc, Calgary, AB, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3583
引用
收藏
页数：2
相关论文
共 50 条
  • [21] A Phase I Dose Escalation and Pharmacodynamic Study of SU5416 (Semaxanib) Combined with Weekly Cisplatin and Irinotecan in Patients with Advanced Solid Tumors
    Martin, Ludmila K.
    Bekaii-Saab, Tanios
    Serna, Derek
    Monk, Paul
    Clinton, Steven K.
    Greyer, Michael R.
    Kraut, Eric H.
    ONKOLOGIE, 2013, 36 (11): : 657 - 660
  • [22] A phase I dose-escalation pharmacokinetic and pharmacodynamic study of INGN 241 (Ad-mda7) in patients with advanced solid tumors
    Cunningham, CC
    Richards, D
    Tong, A
    Zhang, Y
    Su, D
    Chada, S
    Mhashilkar, A
    Zhou-Yang, H
    Parker, K
    Wilson, D
    Nemunaitis, J
    Merritt, J
    Coffee, K
    CANCER GENE THERAPY, 2003, 10 : S2 - S3
  • [23] A dose escalation (DE), pharmacokinetic (PK), and pharmacodynamic (PD) study of OSI-930 and erlotinib (E) in patients (pts) with advanced solid tumors
    Macpherson, I.
    Stewart, K.
    Chick, J.
    Brock, K.
    Poondru, S.
    Gedrich, R.
    Stephens, A. W.
    Evans, T. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [24] Phase I Dose-Escalation and Pharmacokinetic Study of Dasatinib in Patients with Advanced Solid Tumors
    Demetri, George D.
    Lo Russo, Patricia
    MacPherson, Lain R. J.
    Wang, Ding
    Morgan, Jeffrey A.
    Brunton, Valerie G.
    Paliwal, Prashni
    Agrawal, Shruti
    Voi, Maurizio
    Evan, T. R. Jeffry
    CLINICAL CANCER RESEARCH, 2009, 15 (19) : 6232 - 6240
  • [25] Phase I dose escalation study of docetaxel with filgrastim support in patients with advanced solid tumors
    Masters, GA
    Brockstein, BE
    Mani, S
    Ratain, MJ
    MEDICAL ONCOLOGY, 2003, 20 (01) : 7 - 12
  • [26] A dose escalation study of the biweekly administration of paclitaxel, oxaliplatin and capecitabine in patients with advanced solid tumors
    Saridaki, Zacharenia
    Bozionelou, Vasiliki
    Kentepozidis, Nikolaos
    Kotsakis, Athanasios
    Vardakis, Nikolaos
    Kalykaki, Antonia
    Gioulbasanis, Ioannis
    Karabeazis, Athanasios
    Vamvakas, Lambros
    Georgoulias, Vassilis
    Mavroudis, Dimitris
    ONCOLOGY, 2007, 72 (1-2) : 45 - 50
  • [27] Phase I Dose-Escalation Study of Ramucirumab in Chinese Patients with Advanced Solid Tumors
    Cao, Junning
    Ji, Dongmei
    Chen, Zhiyu
    Shen, Weina
    Wang, Jin
    Li, Baoyue
    Chi, Haidong
    Long, Amanda
    Gao, Ling
    Li, Jin
    ONCOLOGIST, 2017, 22 (06): : 638 - +
  • [28] Phase I dose escalation study of docetaxel with filgrastim support in patients with advanced solid tumors
    Gregory A. Masters
    Bruce E. Brockstein
    Sridhar Mani
    Mark J. Ratain
    Medical Oncology, 2003, 20 : 7 - 12
  • [29] A phase I dose escalation study of sunitinib plus capecitabine in patients with advanced solid tumors
    Sweeney, C.
    Verschraegen, C.
    Chiorean, G.
    Lee, F.
    Jones, S.
    Tye, L.
    Bello, A.
    Chao, R.
    Burris, H., III
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [30] A dose escalation study of docetaxel plus capecitabine in combination with gemcitabine in patients with advanced solid tumors
    Amarantidis, K.
    Houhouli, K.
    Papatheodorou, K.
    Miloussis, A.
    Matthaios, D.
    Chatzaki, E.
    Lyrantzopoulos, N.
    Tsaroucha, A.
    Tentes, A.
    Kakolyris, S.
    ONCOLOGY RESEARCH, 2006, 16 (06) : 281 - 287
12345